P&C Labs is a specialty pharmaceutical company that addresses critical needs for niche markets by developing and manufacturing a portfolio of high value solid, semi-solid and liquid products. P&C Labs offers an assortment of prescription products that treat tuberculosis infections, and metabolic and dermatologic conditions as well as non-prescription products that treat a range of digestive and dermatologic conditions. We have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plant are approved by prestigious Egyptian Drug Authority. Our R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. We have a team of over 30 experienced scientists specializing in formulation development and analytical development. We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally. The company has achieved global recognition within a very short span of time and has major expansion plans for the near future. Our products are offered matching the specification and quality requirements set down by our customers. Product grades are available meeting EP, BP, USP protocols and analytical standards. APIs and formulated products are supplied within the parameters set down by the regulatory framework of the Drug Master File authorities. Products are supported by Certificates of Analysis, specifications, conformity to protocols such as EP/BP/USP.
